Drug
Vtx 002
Vtx 002: highest development phase Phase 1/2, developed by Vector Y Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Vector Y Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| VTx-002 NCT07287397 | Phase 1/2 | Amyotrophic Lateral Sclerosis |
Latest
No recent events.
Follow Vtx 002 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.